Ignite Creation Date:
2024-05-06 @ 3:10 AM
Last Modification Date:
2024-10-26 @ 11:29 AM
Study NCT ID:
NCT02225015
Status:
UNKNOWN
Last Update Posted:
2016-06-09
First Post:
2014-08-21
Brief Title:
Cancer Prevention in Women With a BRCA Mutation
Sponsor:
Womens College Hospital
Organization:
Womens College Hospital
Study Overview
Official Title:
Cancer Prevention in Women With a BRCA Mutation A Follow-up Genetic Counselling Intervention
Status:
UNKNOWN
Status Verified Date:
2016-06
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study aims to develop a follow-up telephone-based genetic counselling FTGC intervention for women with a BRCA1 or BRCA2 mutation who have received genetic counseling in the past Typically when women undergo genetic testing they receive standard genetic counselling prior to testing in order to fully understand the procedure and associated implications If a womans genetic test results are positive for a mutation cancer prevention options are then discussed with a counsellor However in Canada there is currently no formal follow-up counselling for women with a BRCA mutation to provide ongoing guidance and support about latest risk reduction strategies Standard care relies on women making contact for any follow-up questions or concerns they may have As a result these women might not have the most current information regarding genetic risk assessment and prevention options Therefore individuals are being asked to participate in this study to aid research about the efficacy of FTGC in women with a BRCA mutation
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None